Katherine Gorrell joins BioStem Technologies to oversee legal and compliance functions, supporting company growth and governance. LakeShore Biopharma enters a merger agreement with Oceanpine Skyline Inc., becoming a wholly owned subsidiary with an equity value of US$2.7 million.
